Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis
about
Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker studyHuman alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequencesRoles of antimicrobial peptides such as defensins in innate and adaptive immunityElevated Concentration of Defensins in Hepatitis C Virus-Infected PatientsA systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analysesHuman defensin alpha-1 causes Trypanosoma cruzi membrane pore formation and induces DNA fragmentation, which leads to trypanosome destruction.Human neutrophil peptides and complement factor Bb in pathogenesis of acquired thrombotic thrombocytopenic purpuraIncreased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progressionRole of defensins in the pathogenesis of chronic lung allograft rejection.Human Neutrophil Peptide 1 Limits Hypercholesterolemia-induced Atherosclerosis by Increasing Hepatic LDL ClearanceDual role of alpha-defensin-1 in anti-HIV-1 innate immunity.Dynamic changes in neutrophil defensins during endotoxemia.ClpX contributes to innate defense peptide resistance and virulence phenotypes of Bacillus anthracis.Individual and synergistic effects of rabbit granulocyte proteins on Escherichia coli.Human alpha-defensins block papillomavirus infectionHuman defensins facilitate local unfolding of thermodynamically unstable regions of bacterial protein toxins.Sub-inhibitory concentrations of human α-defensin potentiate neutralizing antibodies against HIV-1 gp41 pre-hairpin intermediates in the presence of serum.Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis.Defensins and other antimicrobial peptides at the ocular surfaceIncreased plasma arginase activity in human sepsis: association with increased circulating neutrophils.Immunohistochemical localization of defensin in human coronary vessels.High fidelity processing and activation of the human α-defensin HNP1 precursor by neutrophil elastase and proteinase 3Inhibition of pathologic retinal neovascularization by alpha-defensins.Amniotic fluid exhibits an innate inhibitory activity against HIV type 1 replication in vitroSuppression of hepatic glucose production by human neutrophil alpha-defensins through a signaling pathway distinct from insulin.Murine beta-defensin 2 promotes TLR-4/MyD88-mediated and NF-kappaB-dependent atypical death of APCs via activation of TNFR2Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP.Increased alpha-defensin expression is associated with risk of coronary heart disease: a feasible predictive inflammatory biomarker of coronary heart disease in hyperlipidemia patientsCellular response to Trypanosoma cruzi infection induces secretion of defensin α-1, which damages the flagellum, neutralizes trypanosome motility, and inhibits infection.Human neutrophil peptides and phagocytic deficiency in bronchiectatic lungs.Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases.A list of candidate cancer biomarkers for targeted proteomics.Comprehensive defensin assay for saliva.The virulence regulator Sae of Staphylococcus aureus: promoter activities and response to phagocytosis-related signals.Low concentrations of human neutrophil peptide ameliorate experimental murine colitis.Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulationNeutrophil alpha-defensins cause lung injury by disrupting the capillary-epithelial barrier.Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa.Human alpha-defensins inhibit hemolysis mediated by cholesterol-dependent cytolysins.
P2860
Q21260439-948B66E1-E89C-46CD-A287-6811E2757044Q24555744-30A32CF3-52FD-4091-A527-AA70FA0BFFF1Q24675023-BA859FE2-44A1-44F5-9405-E65ADD4F1252Q27469045-9A0A5B6F-1125-4E37-BE7C-BE9662BE29C3Q28732696-1F905CC3-3830-4423-99A1-7F6AAD6F7874Q30179435-7D27FDAC-5826-4564-A928-7D6D01CADDA7Q33435545-87193B0E-7CEA-4A71-B746-53F692C103F9Q33535953-D1ECFF7B-1010-49E9-8149-E0EDB30F6ACCQ33570756-4660764F-7334-4245-B112-EE3B9F12792CQ33809459-DB4C2B44-7837-44A5-A687-0EB57360A286Q33842057-6FF8851B-F069-464F-B4E3-45DEB8A30DB8Q34009878-B6746074-961F-4FCE-A90C-A133E408B29DQ34061669-7002A92E-67A2-4D34-8598-D6050CF63C98Q34229105-AD59566A-8308-423D-BC98-EEC85C748CF6Q34334899-857B1709-AD46-4BB2-8C8B-4B5396867827Q34727874-5D1FBA44-1BCA-4675-B670-72B9AA17744AQ34778515-9981807F-FD0F-467F-9441-30E3D83BD9BFQ35010044-76C0524F-C38D-45E2-833A-27B7DC9D4182Q35535282-055846DB-F591-4124-8CB1-74015A076E24Q35594084-9CE04146-B6B6-40D6-8F5C-C13E2E68E388Q35607212-D1D003AB-8CE6-469A-A078-36BB204B9615Q35763559-64085433-409C-4614-88C5-E88C08C55891Q35842408-2079ACEE-90F9-4F42-BE02-86A48DA503FFQ35847765-5F0D21D2-AAEE-4671-8904-454C3D2AECB4Q36509605-442C0A75-2230-4D71-BFCC-DB4F39D4E3D1Q36585589-A23228BB-7E87-4EEE-B2FD-51521647A594Q36628410-AFA69CCD-0CB3-47EA-86F3-3AA62CDA1AD5Q37076408-6918434C-2E11-4F1C-9B60-0C3A45CDD369Q37105734-8535808A-E7BA-420A-915A-A73C7B4C5B64Q37264811-5EF416ED-83A7-403A-A5DC-B71C19F47D45Q37272618-AA5E2BEF-ACF9-4C3E-8081-3D28631B8DFBQ37275036-50EEF74C-FB7D-48B2-A2EE-2EC864D78E35Q37277962-5C7B44A4-6AF0-4C10-BB30-D458879C47F0Q37408461-96BB9E6A-4D66-47C7-8EDA-57CC81A467FDQ38608662-28F35865-8458-4FF5-B848-1977D2E3C025Q39190445-EE273B6C-467C-4542-AC0A-7D308C4EEAD6Q39810189-5A19DA6D-3811-484C-8B60-3E295B6250E4Q40287076-C21ACC0C-4DAB-4551-9C15-4A913C28950FQ41973212-54B82380-582E-4861-9E03-E00B7E1621B7Q42089675-AE8EC8CC-1E25-44E7-880E-506209704CD1
P2860
Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Plasma defensin concentrations ...... icemia or bacterial meningitis
@ast
Plasma defensin concentrations ...... icemia or bacterial meningitis
@en
Plasma defensin concentrations ...... icemia or bacterial meningitis
@nl
type
label
Plasma defensin concentrations ...... icemia or bacterial meningitis
@ast
Plasma defensin concentrations ...... icemia or bacterial meningitis
@en
Plasma defensin concentrations ...... icemia or bacterial meningitis
@nl
prefLabel
Plasma defensin concentrations ...... icemia or bacterial meningitis
@ast
Plasma defensin concentrations ...... icemia or bacterial meningitis
@en
Plasma defensin concentrations ...... icemia or bacterial meningitis
@nl
P2093
P921
P3181
P1476
Plasma defensin concentrations ...... icemia or bacterial meningitis
@en
P2093
A V Panyutich
E A Baturevich
E A Panyutich
V A Krapivin
P3181
P407
P577
1993-08-01T00:00:00Z